Search

everythinglearnresearchcommunity

for

Search:↓

Men with baldness at the front and top of their head at age 45 may have a higher risk of aggressive prostate cancer.

New treatments are making advanced prostate cancer management more complex but also more hopeful.

A man developed male breast cancer after four years of finasteride treatment for an enlarged prostate.

Serum triglyceride levels are not linked to prostate cancer risk.

Doxil showed some effectiveness against advanced prostate cancer but caused severe side effects at higher doses.

Keratins help protect cells, aid in cancer diagnosis, and influence cancer behavior and treatment.

Certain genetic variants increase the risk of resistance to hormone therapy in prostate cancer patients.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

sPLA2-IIA increases growth in hair follicle stem cells and cancer cells, suggesting it could be targeted for hair growth and cancer treatment.

Dutasteride may help shrink prostate cancer tumors.

Age, race, family history, and certain genetic factors increase prostate cancer risk.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

Physical activity, height, and smoking affect prostate cancer risk.

5α-reductase inhibitors may help with prostate cancer but could increase the risk of severe tumors, so careful use is advised.

Certain plasma proteins are linked to prostate cancer risk and could help in early detection and treatment.

Black ethnicity, prior PSA tests, enlarged prostate, and family history increase prostate cancer risk; Asian ethnicity, obesity, smoking, diabetes, and less sexual activity or no children decrease risk.

Men who start balding at age 20 may have a higher chance of getting aggressive prostate cancer.

Inhibiting 5α-reductase can help reduce prostate cancer risk and improve treatment.

Stem cells are crucial for tissue growth, cancer treatment, and disease modeling, but challenges remain in clinical use.

Vertex pattern hair loss linked to higher prostate cancer risk.

Steroid 5α-reductase evolved from protists and diversified in eukaryotes, with specific roles in mammals and plants.

Flutamide rarely causes liver toxicity in prostate cancer patients.

Men with melanoma have a higher risk of later being diagnosed with prostate cancer.

Tridax procumbens extracts may help treat cancer due to their strong anticancer and antioxidant properties.

Low dose finasteride causes only minor changes in PSA levels in men over 50 with BPH.

The new compound was more effective than finasteride in reducing markers of hair loss and prostate issues in cell tests.

Genetic differences may affect COVID-19 deaths; anti-androgens could be potential treatment.